Skip to main content
. Author manuscript; available in PMC: 2018 Jan 5.
Published in final edited form as: Vaccine. 2016 Nov 29;35(2):264–272. doi: 10.1016/j.vaccine.2016.11.072

Fig. 3. Analysis of anti-Pfs48/45 titers by ELISA in mice (n=5) immunized with different Pfs48/45 DNA vaccines.

Fig. 3

(a) shows average end-point titers after 3 DNA immunizations and (b) shows average end-point titers after a r-Pfs48/45 protein boost in the groups that received 25 and 5 ug plasmid DNA doses. End-point titers were defined as reciprocal of serum dilutions giving an absorbance (405nm) higher than that with pre-immune sera + 3SD. Statistically significant differences between groups were determined by student t-test; p < 0.001 – 0.05, indicated by (*). The error bars indicate SD.